324 related articles for article (PubMed ID: 27436303)
1. Kidney Function Does Not Modify the Favorable Quality of Life Changes Associated With Revascularization for Coronary Artery Disease: Cohort Study.
James MT; Wilton SB; Clement FM; Ghali WA; Knudtson ML; Tan Z; Tonelli M; Hemmelgarn BR; Norris CM;
J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27436303
[TBL] [Abstract][Full Text] [Related]
2. Quality of life following coronary artery bypass graft surgery vs. percutaneous coronary intervention in diabetics with multivessel disease: a five-year registry study.
McGrath BM; Norris CM; Hardwicke-Brown E; Welsh RC; Bainey KR
Eur Heart J Qual Care Clin Outcomes; 2017 Jul; 3(3):216-223. PubMed ID: 28838087
[TBL] [Abstract][Full Text] [Related]
3. Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery.
Cohen DJ; Van Hout B; Serruys PW; Mohr FW; Macaya C; den Heijer P; Vrakking MM; Wang K; Mahoney EM; Audi S; Leadley K; Dawkins KD; Kappetein AP;
N Engl J Med; 2011 Mar; 364(11):1016-26. PubMed ID: 21410370
[TBL] [Abstract][Full Text] [Related]
4. Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisons.
Arnold SV; Magnuson EA; Wang K; Serruys PW; Kappetein AP; Mohr FW; Cohen DJ;
Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):267-75. PubMed ID: 22496114
[TBL] [Abstract][Full Text] [Related]
5. Long-term patient and kidney survival after coronary artery bypass grafting, percutaneous coronary intervention, or medical therapy for patients with chronic kidney disease: a propensity-matched cohort study.
Vuurmans T; Er L; Sirker A; Djurdjev O; Simkus G; Levin A
Coron Artery Dis; 2018 Jan; 29(1):8-16. PubMed ID: 28938241
[TBL] [Abstract][Full Text] [Related]
6. Outcome after coronary artery bypass grafting and percutaneous coronary intervention in patients with stage 3b-5 chronic kidney disease.
Lautamäki A; Kiviniemi T; Biancari F; Airaksinen J; Juvonen T; Gunn J
Eur J Cardiothorac Surg; 2016 Mar; 49(3):926-30. PubMed ID: 26142469
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Versus Without Chronic Kidney Disease.
Yamamoto K; Natsuaki M; Morimoto T; Shiomi H; Takeji Y; Kadota K; Imada K; Toyofuku M; Kanemitsu N; Shinoda E; Suwa S; Iwakura A; Tamura T; Soga Y; Inada T; Matsuda M; Koyama T; Aoyama T; Kato E; Sato Y; Furukawa Y; Ando K; Yamazaki F; Komiya T; Minatoya K; Nakagawa Y; Kimura T
Am J Cardiol; 2021 Apr; 145():37-46. PubMed ID: 33454346
[TBL] [Abstract][Full Text] [Related]
8. Comparative Effectiveness of Medical Therapy, Percutaneous Revascularization, and Surgical Coronary Revascularization in Cardiovascular Risk Subgroups of Patients With CKD: A Retrospective Cohort Study of Medicare Beneficiaries.
Charytan DM; Natwick T; Solid CA; Li S; Gong T; Herzog CA
Am J Kidney Dis; 2019 Oct; 74(4):463-473. PubMed ID: 31255335
[TBL] [Abstract][Full Text] [Related]
9. Relative benefit of coronary artery bypass grafting versus stent-assisted percutaneous coronary intervention for angina pectoris and multivessel coronary disease in women versus men (one-year results from the Stent or Surgery trial).
Zhang Z; Weintraub WS; Mahoney EM; Spertus JA; Booth J; Nugara F; Stables RH; Vaccarino V
Am J Cardiol; 2004 Feb; 93(4):404-9. PubMed ID: 14969611
[TBL] [Abstract][Full Text] [Related]
10. Disease-specific health status after stent-assisted percutaneous coronary intervention and coronary artery bypass surgery: one-year results from the Stent or Surgery trial.
Zhang Z; Mahoney EM; Stables RH; Booth J; Nugara F; Spertus JA; Weintraub WS
Circulation; 2003 Oct; 108(14):1694-700. PubMed ID: 12975252
[TBL] [Abstract][Full Text] [Related]
11. Economic Analysis of Surgical and Interventional Treatments for Patients with Complex Coronary Artery Disease: Insights from a One-Year Single-Center Study.
Zhao Y; Meng S; Liu T; Dong R
Med Sci Monit; 2020 Feb; 26():e919374. PubMed ID: 32097388
[TBL] [Abstract][Full Text] [Related]
12. Revascularization in Patients With Multivessel Coronary Artery Disease and Chronic Kidney Disease: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery.
Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL
J Am Coll Cardiol; 2015 Sep; 66(11):1209-1220. PubMed ID: 26361150
[TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life outcomes of patients with coronary artery disease treated with cardiac surgery, percutaneous coronary intervention or medical management.
Norris CM; Saunders LD; Ghali WA; Brant R; Galbraith PD; Graham M; Faris P; Dzavik V; Knudtson ML;
Can J Cardiol; 2004 Oct; 20(12):1259-66. PubMed ID: 15494780
[TBL] [Abstract][Full Text] [Related]
14. Health status and quality of life in patients with stable coronary artery disease and chronic kidney disease treated with optimal medical therapy or percutaneous coronary intervention (post hoc findings from the COURAGE trial).
Sedlis SP; Jurkovitz CT; Hartigan PM; Kolm P; Goldfarb DS; Lorin JD; Dada M; Maron DJ; Spertus JA; Mancini GB; Teo KK; Boden WE; Weintraub WS;
Am J Cardiol; 2013 Dec; 112(11):1703-8. PubMed ID: 24011740
[TBL] [Abstract][Full Text] [Related]
15. Impact of chronic kidney disease on patients with unprotected left main coronary artery disease treated with coronary artery bypass grafting or drug-eluting stents.
Pan Y; Qiu Q; Chen F; Li X; Yu X; Luo Y; Li Q; He J; Gao Y; Zhang X; Ren X
Coron Artery Dis; 2016 Nov; 27(7):535-42. PubMed ID: 27269882
[TBL] [Abstract][Full Text] [Related]
16. Quality of Life After Fractional Flow Reserve-Guided PCI Compared With Coronary Bypass Surgery.
Fearon WF; Zimmermann FM; Ding VY; Zelis JM; Piroth Z; Davidavicius G; Mansour S; Kharbanda R; Östlund-Papadogeorgos N; Oldroyd KG; Wendler O; Reardon MJ; Woo YJ; Yeung AC; Pijls NHJ; De Bruyne B; Desai M; Hlatky MA;
Circulation; 2022 May; 145(22):1655-1662. PubMed ID: 35369704
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Quality-of-Life Outcomes With Invasive Versus Conservative Management of Chronic Coronary Disease in ISCHEMIA.
Mark DB; Spertus JA; Bigelow R; Anderson S; Daniels MR; Anstrom KJ; Baloch KN; Cohen DJ; Held C; Goodman SG; Bangalore S; Cyr D; Reynolds HR; Alexander KP; Rosenberg Y; Stone GW; Maron DJ; Hochman JS;
Circulation; 2022 Apr; 145(17):1294-1307. PubMed ID: 35259918
[TBL] [Abstract][Full Text] [Related]
18. Effects of Ranolazine on Angina and Quality of Life After Percutaneous Coronary Intervention With Incomplete Revascularization: Results From the Ranolazine for Incomplete Vessel Revascularization (RIVER-PCI) Trial.
Alexander KP; Weisz G; Prather K; James S; Mark DB; Anstrom KJ; Davidson-Ray L; Witkowski A; Mulkay AJ; Osmukhina A; Farzaneh-Far R; Ben-Yehuda O; Stone GW; Ohman EM
Circulation; 2016 Jan; 133(1):39-47. PubMed ID: 26555329
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous revascularization improves outcomes in patients with prior coronary artery bypass surgery.
Gyenes G; Norris CM; Graham MM;
Catheter Cardiovasc Interv; 2013 Sep; 82(3):E148-54. PubMed ID: 23208677
[TBL] [Abstract][Full Text] [Related]
20. Comparative Efficacy of Coronary Revascularization Procedures for Multivessel Coronary Artery Disease in Patients With Chronic Kidney Disease.
Roberts JK; Rao SV; Shaw LK; Gallup DS; Marroquin OC; Patel UD
Am J Cardiol; 2017 May; 119(9):1344-1351. PubMed ID: 28318510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
